Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.
Effect of an Intradialytic Physical Exercise Programme Supplemented With Creatine Monohydrate on Body Composition, Biochemical Parameters and Functionality in Patients With Stage 5 Chronic Kidney Disease Undergoing Haemodialysis: Phase II Double-blind Randomised Clinical Trial.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
A double-blind, randomized clinical trial will be conducted in patients with chronic kidney disease undergoing maintenance hemodialysis. The study will evaluate the effects of creatine monohydrate supplementation and an intradialytic exercise program on body composition, biochemical parameters, and functional capacity.
Participants will be allocated to one of four study groups: (1) standard hemodialysis care, (2) creatine monohydrate supplementation, (3) intradialytic exercise, and (4) creatine monohydrate supplementation combined with intradialytic exercise. The intervention period will last 8 weeks.
Body composition, biochemical parameters, and functional capacity will be assessed at baseline and after completion of the intervention period. Comparisons among study groups will be performed to determine the independent and combined effects of creatine monohydrate supplementation and intradialytic exercise.
The study is designed to generate evidence regarding the potential clinical benefits of incorporating structured exercise programs and creatine supplementation into the routine management of patients receiving maintenance hemodialysis. Findings may contribute to the development of strategies aimed at improving physical function, nutritional status, and overall health outcomes in this population.
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 2
- Fas 1
Kontakter och platser
Studiekontakt
- Namn: Israel Pérez Palafox PALAFOX Master of Medical Sciences
- Telefonnummer: +523151260402
- E-post: iperez@ucol.mx
Studieorter
-
-
Coliima
-
Colima, Coliima, Mexiko, 28048
- Rekrytering
- IMSS-Bienestar State Haemodialysis Centre
-
Kontakt:
- Evalyn Ceballos Medica cirujana y partera
- Telefonnummer: 3121078792
- E-post: eveceballoss@gmail.com
-
Underutredare:
- Pedro Julian Flores Moreno, Doctor of Medical Sciences
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
atients who are treated at the State Haemodialysis Centre.
- Patients who receive haemodialysis three times a week.
- Signature of informed consent.
- Patients over 18 years of age, both men and women.
- Patients who have been on haemodialysis for no more than two years.
Exclusion Criteria:
Patients who have had a limb amputated.
- Patients who are in a state of anuria.
- Inability to perform muscular resistance or aerobic resistance exercises.
- Patients unable to perform physical exercise.
- HIV-positive patients. Elimination.
- Patients who voluntarily withdraw from the project.
- Inability to perform physical exercise.
- Death.
- Adverse events related to creatine consumption.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Group A
consists of hemodialysis, intradialytic exercise, and creatine monohydrate.
|
Participants will receive 5 g of creatine monohydrate diluted in 100 mL of water daily for 8 weeks.
On hemodialysis days, supplementation will be administered immediately after the dialysis session.
On non-dialysis days, supplementation will be administered after a meal.
|
|
Placebo-jämförare: Group B
consists of hemodialysis, intradialytic exercise, and placebo.
|
Participants will receive 5 g of placebo diluted in 100 mL of water daily for 8 weeks.
On hemodialysis days, placebo will be administered immediately after the dialysis session.
On non-dialysis days, placebo will be administered after a meal.
|
|
Aktiv komparator: Group C
consists of hemodialysis and exercise.
|
Participants will perform a supervised intradialytic exercise program during hemodialysis sessions for 8 weeks.
The program will include aerobic and resistance exercises performed three times per week according to the study protocol.
|
|
Sham Comparator: Group D
consists of hemodialysis.
|
Participants will continue receiving their prescribed maintenance hemodialysis treatment according to the standard clinical procedures of the dialysis center.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Grasping muscle strength
Tidsram: From baseline assessments through the end of the 8-week intervention
|
Measurement of results in kilograms
|
From baseline assessments through the end of the 8-week intervention
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CEI2026/01/CR/CL/SFD/205
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- ICF
Studiedata/dokument
-
Studieprotokoll
Informationsidentifierare: Permit requiredInformationskommentarer: request permission through the link
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .